Therapy Areas: Infectious Diseases
Copper Compression Donates 18,000 Reusable Copper-Infused Masks to New York/New Jersey Metro-Area Health Systems to Aid in Fight Against COVID-19
8 April 2020 - - US-based Copper Compression, a designer, manufacturer and provider of a range of copper-infused recovery wearables and self-care solutions, has donated and delivered 18,000 Kn99 coppe...
The international iReceptor Plus consortium to launch technology tools and infrastructure to aid COVID-19 treatment
7 April 2020 - The international iReceptor Plus consortium, an international project co-funded by the EU and the Canadian government, is launching the technology tools and infrastructure developed wit...
Friends of Animals recommends WHO, UN to shut down wildlife markets to avoid another pandemic
7 April 2020 - Animal protection company Friends of Animals announced Monday that it has directed the World Health Organization and the United Nations to avoid another pandemic by shuttering world wet...
Ridgeback LP wins FDA clearance to commence human testing of EIDD-2801 for potential treatment for COVID-19
7 April 2020 - Biotechnology company Ridgeback Biotherapeutics LP said on Monday that it has received US Food and Drug Administration (FDA) approval to initiate human clinical testing of investigation...
FHI Clinical Partners with Seattle Not-for-Profit Infectious Disease Research Institute in Providing CRO Capabilities for Coronavirus (COVID-19) Clinical Trial
6 April 2020 - - US-based FHI Clinical Inc.  has partnered with Seattle-based not-for-profit organisation Infectious Disease Research Institute to provide full-service contract research orga...
PledPharma announces preventive measures for AGM in light of COVID-19 spread
3 April 2020 - PledPharma AB (STO: PLED), an integrated, pharmaceutical drug development company, announced on Thursday its decision to take a number of preventive measures before the annual general m...
Related Headlines

Aptorum Group Teams with Covar Pharmaceuticals to Investigate at Least 3 Repurposed Drug Candidates

Thermo unveils new AcroMetrix COVID-19 RNA control to monitor and validate COVID-19 molecular diagnostic tests

Generation Bio and Vir biotechnology Will on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Use Against SARS-CoV-2Coronavirus

Dassault Systèmes Supports Simulation and Prevention of Contamination Dispersal in Wuhan's Leishenshan Hospital

Fluxergy files for FDA Emergency Use Authorization (EUA) for one-hour COVID-19 test at POC

Aquavit Pharmaceuticals files two patent applications with the United States Patent and Trademark Office

Bold Therapeutics suggests potential utility of BOLD-100 as novel antiviral agent

Abbott introduces fast molecular point-of-care test to detect COVID-19

Innoplexus uses AI discovery platform to find potential combinations of prior approved drugs for COVID-19

Innoplexus reveals certain first results in artificial intelligence enabled search for COVID-19 treatment

Lumos Diagnostics Supports the Victorian Healthcare System by Providing FebriDx for a Pilot Evaluation in the Triaging of Acute Respiratory Infection Patients

Inovio Reports Positive Interim Phase 2 VGX-3100 Results in Patients with HPV-associated Anal Dysplasia

Nuclein to Expedite Commercialisation of Hand-Held PCR Test to Aid in COVID-19 Pandemic

Mesa Biotech granted FDA Emergency Use Authorization for 30 minute POC molecular COVID-19 Test

Cumberland Pharmaceuticals looks to increase availability of treatment for pneumonia due to COVID-19